Lonikan

Synthetic adrenocorticosteroid with prevailing mineralocorticoid action. Indicated for the treatment of the salt-losing adrenogenital syndrome, primary or secondary adrenocortical insufficiency in Addison disease.

Therapeutic Area
Synthetic Adrenocorticoid

Active Ingredient
Fludrocortisone

Line
Cardiometabolism

Pharmaceutical Form
0.1 mg tablets x 50

Download Leaflet Descargar